Previous studies suggest that IRF-1 has an anti-tumor effect through growth inhibition and induction of apoptotic genes including caspase, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), and lysyl oxidase (LOX) [27]. The gene discussed is TNFSF10; the disease is neoplasm.